Interventional oncology Market by Procedure [Embolization (TARE, TACE), Ablation (Thermal Ablation (Microwave, RF Ablation))], Product [Embolization (SIR-Spheres, TheraSpheres)], Application (Liver, Lung, Breast), and End User - Global Forecast to 2025

  • Report ID:MRHC - 104312
  • Pages: 251
  • Jul 2019
  • Formats*: PDF
  • Category: Healthcare

1. Introduction
    1.1. Market Ecosystem
    1.2. Currency and Limitations
           1.2.1. Currency
           1.2.2. Limitations
    1.3. Key Stakeholders

2. Research Methodology
    2.1. Secondary Research
    2.2. Primary Research

3. Executive Summary

4. Market insights
    4.1. Introduction
    4.2. Market Dynamics
           4.2.1. Drivers
                     4.2.1.1. Growing Preference for Minimally invasive Treatment Procedures
                     4.2.1.2. Increasing Incidence & Prevalence of Cancer
                     4.2.1.3. Rising Number of Hospitals
                     4.2.1.4. Technological Advancements in the Field of Radiology
           4.2.2. Restraints
                     4.2.2.1. Potential Risks Associated with Interventional Oncology Procedures
                     4.2.2.2. High Cost Associated with Interventional Oncology Procedures
                     4.2.2.3. Paucity of Skilled Healthcare Professionals
           4.2.3. Opportunities
                     4.2.3.1. Significant Growth Opportunities from Emerging Asian and Latin American Markets
                     4.2.3.2. Introduction of Cloud-Based Medical Imaging
           4.2.4. Trend
                     4.2.4.1. Growing Integration of Image-Guided Solutions with Interventional Oncology Procedures

5. Interventional Oncology Market, by Procedure
    5.1. Introduction
    5.2. Tumor Embolization
           5.2.1. Transarterial Radioembolization (TARE)
           5.2.2. Transarterial Chemoembolization (TACE)
           5.2.3. Bland Embolization
    5.3. Tumor Ablation
           5.3.1. Thermal Ablation
                     5.3.1.1. Radiofrequency Ablation (RFA)
                     5.3.1.2. Microwave Ablation (MWA)
                     5.3.1.3. Cryoablation
                     5.3.1.4. Other Thermal Ablation Procedures
           5.3.2. Non-Thermal Ablation

6. Interventional Oncology Market, by Product
    6.1. Introduction
    6.2. Tumor Embolization
           6.2.1. Radioembolic Agents
                     6.2.1.1. Sir-Spheres
                     6.2.1.2. TheraSphere
                     6.2.1.3. QuiremSpheres
           6.2.2. Non-Radioactive Embolic Agents
                     6.2.2.1. Microspheres
                     6.2.2.2. Particles (PVA Particles and Gelfoam Particles)
                     6.2.2.3. Drug-Eluting Beads (DEBs)
    6.3. Tumor Ablation
           6.3.1. Tumor Ablation Devices/Generators
           6.3.2. Consumables & Accessories

7. Interventional Oncology Market, by Application
    7.1. Introduction
    7.2. Liver Cancer
    7.3. Lung Cancer
    7.4. Breast Cancer
    7.5. Prostate Cancer
    7.6. Kidney Cancer
    7.7. Bone Metastasis
    7.8. Other Cancers

8. Interventional Oncology Market, by End User
    8.1. Introduction
    8.2. Hospitals
    8.3. Ambulatory Surgery Centres
    8.4. Research and Academia

9. Interventional Oncology Market, by Geography
    9.1. Introduction
    9.2. North America
           9.2.1. U.S.
           9.2.2. Canada
    9.3. Europe
           9.3.1. Germany
           9.3.2. France
           9.3.3. U.K.
           9.3.4. Italy
           9.3.5. Spain
           9.3.6. Rest of Europe
    9.4. Asia-Pacific
           9.4.1. Japan
           9.4.2. China
           9.4.3. India
           9.4.4. Rest of Asia-Pacific
    9.5. Rest of World
           9.5.1. Latin America
           9.5.2. Middle East & Africa

10. Competitive Landscape
      10.1. Growth Strategies
      10.2. Competitive Benchmarking
      10.3. Market Share Analysis (2018)

11. Company Profiles(Business Overview, Financial Overview, Product Portfolio, Strategic Developments)
      11.1. Boston Scientific Corporation
      11.2. Cook Medical LLC (A Subsidiary of Cook Group)
      11.3. Merit Medical Systems, Inc.
      11.4. C. R. Bard, Inc. (A Subsidiary of Becton Dickinson & Company)
      11.5. Profound Medical Corp.
      11.6. AngioDynamics, Inc.
      11.7. BTG plc
      11.8. Terumo Corporation
      11.9. Medtronic plc
      11.10. Healthtronics, Inc.
      11.11. EDAP TMS S.A.
      11.12. Neuwave Medical, Inc. (Subsidiary of Ethicon Inc.)
      11.13. Sirtex Medical Limited
      11.14. Trod Medical
      11.15. Teleflex Incorporated
      11.16. IMBiotechnologies Ltd.

12. Appendix
      12.1. Questionnaire
      12.2. Available Customization

List of Tables

Table 1 Global Interventional Oncology Market Drivers: Impact Analysis (2019-2025)
Table 2 Global Interventional Oncology Market Restraints: Impact Analysis (2019-2025)
Table 3 Cost of Ablation Treatment (For 3cm Kidney Lesion)
Table 4 Global Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 5 Global Tumor Embolization Market Size, by Type, 2017-2025 ($Million)
Table 6 Global Tumor Embolization Market Size, by Country, 2017-2025 ($Million)
Table 7 Global Transarterial Radioembolization Market Size, by Country, 2017-2025 ($Million)
Table 8 Global Transarterial Chemoembolization Market Size, by Country, 2017-2025 ($Million)
Table 9 Global Bland Embolization Market Size, by Country, 2017-2025 ($Million)
Table 10 Global Tumor Ablation Market Size, by Type, 2017-2025 ($Million)
Table 11 Global Tumor Ablation Market Size, by Country, 2017-2025 ($Million)
Table 12 Global Thermal Ablation Market Size, by Type, 2017-2025 ($Million)
Table 13 Global Thermal Ablation Market Size, by Country, 2017-2025 ($Million)
Table 14 Global Radiofrequency Ablation Market Size, by Country, 2017-2025 ($Million)
Table 15 Global Microwave Ablation Market Size, by Country, 2017-2025 ($Million)
Table 16 Global Cryoablation Market Size, by Country, 2017-2025 ($Million)
Table 17 Global Other Thermal Ablation Procedures Market Size, by Country, 2017-2024 ($Million)
Table 18 Global Irreversible Electroporation Market Size, by Country, 2017-2024 ($Million)
Table 19 Global Interventional Oncology Market Size, by Product, 2017-2025 ($Million)
Table 20 Global Tumor Embolization Market Size, by Product Type, 2017-2025 ($Million)
Table 21 Global Tumor Embolization Market Size, by Country, 2017-2025 ($Million)
Table 22 List of Commercialized Radioembolic Agents
Table 23 Global Radioembolic Agents Market Size, by Product, 2017-2025 ($Million)
Table 24 Global Radioembolic Agents Market Size, by Country, 2017-2025 ($Million)
Table 25 Global Non-Radioactive Embolic Agents Market Size, by Type, 2017-2025 ($Million)
Table 26 Global Non-Radioactive Embolic Agents Market Size, by Country, 2017-2025 ($Million)
Table 27 Global Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 28 Global Tumor Ablation Market, by Country, 2017-2025 ($Million)
Table 29 Global Tumor Ablation Devices/ Generators Market Size, by Country, 2017-2025 ($Million)
Table 30 Global Tumor Ablation Consumables & Accessories Market Size, by Country, 2017-2025 ($Million)
Table 31 Global Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 32 Global Interventional Oncology Market Size for Liver Cancer, by Country, 2017-2025 ($Million)
Table 33 Global Interventional Oncology Market Size for Lung Cancer, by Country, 2017-2025 ($Million)
Table 34 Global Interventional Oncology Market Size for Breast Cancer, by Country, 2017-2025 ($Million)
Table 35 Examples of Products Used for Prostate Cancer Treatment
Table 36 Global Interventional Oncology Market Size for Prostate Cancer, by Country, 2017-2025 ($Million)
Table 37 Global Interventional Oncology Market Size for Kidney Cancer, by Country, 2017-2025 ($Million)
Table 38 Global Interventional Oncology Market Size for Bone Metastasis, by Country, 2017-2025 ($Million)
Table 39 Global Interventional Oncology Market Size for Other Cancers, by Country, 2017-2025 ($Million)
Table 40 Global Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 41 Global Interventional Oncology Market Size for Hospitals, by Country, 2017-2025 ($Million)
Table 42 Global Interventional Oncology Market Size for Ambulatory Surgery Centres, by Country, 2017-2025 ($Million)
Table 43 Global Interventional Oncology Market Size for Research and Academia, by Country, 2017-2025 ($Million)
Table 44 Global Interventional Oncology Market Size, by Country, 2019-2025 ($Million)
Table 45 North America: Interventional Oncology Market Size, by Country, 2017-2025 ($Million)
Table 46 North America: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 47 North America: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 48 North America: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 49 North America: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 50 North America: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 51 North America: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 52 North America: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 53 North America: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 54 U.S.: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 55 U.S.: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 56 U.S.: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 57 U.S.: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 58 U.S.: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 59 U.S.: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 60 U.S.: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 61 U.S.: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 62 Canada: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 63 Canada: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 64 Canada: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 65 Canada: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 66 Canada: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 67 Canada: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 68 Canada: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 69 Canada: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 70 Europe: Interventional Oncology Market Size, by Country, 2017-2025 ($Million)
Table 71 Europe: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 72 Europe: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 73 Europe: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 74 Europe: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 75 Europe: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 76 Europe: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 77 Europe: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 78 Europe: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 79 Germany: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 80 Germany: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 81 Germany: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 82 Germany: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 83 Germany: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 84 Germany: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 85 Germany: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 86 Germany: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 87 France: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 88 France: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 89 France: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 90 France: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 91 France: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 92 France: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 93 France: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 94 France: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 95 U.K.: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 96 U.K.: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 97 U.K.: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 98 U.K.: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 99 U.K.: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 100 U.K.: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 101 U.K.: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 102 U.K.: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 103 Italy: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 104 Italy: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 105 Italy: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 106 Italy: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 107 Italy: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 108 Italy: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 109 Italy: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 110 Italy: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 111 Spain: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 112 Spain: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 113 Spain: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 114 Spain: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 115 Spain: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 116 Spain: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 117 Spain: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 118 Spain: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 119 Interventional Oncology Conferences
Table 120 RoE: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 121 RoE: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 122 RoE: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 123 RoE: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 124 RoE: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 125 RoE: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 126 RoE: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 127 RoE: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 128 Asia-Pacific: Interventional Oncology Market Size, by Country, 2017-2025 ($Million)
Table 129 Asia-Pacific: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 130 Asia-Pacific: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 131 Asia-Pacific: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 132 Asia-Pacific: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 133 Asia-Pacific: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 134 Asia-Pacific: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 135 Asia-Pacific: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 136 Asia-Pacific: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 137 Japan: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 138 Japan: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 139 Japan: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 140 Japan: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 141 Japan: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 142 Japan: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 143 Japan: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 144 Japan: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 145 China: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 146 China: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 147 China: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 148 China: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 149 China: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 150 China: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 151 China: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 152 China: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 153 India: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 154 India: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 155 India: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 156 India: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 157 India: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 158 India: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 159 India: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 160 India: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 161 RoAPAC: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 162 RoAPAC: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 163 RoAPAC: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 164 RoAPAC: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 165 RoAPAC: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 166 RoAPAC: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 167 RoAPAC: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 168 RoAPAC: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 169 RoW: Interventional Oncology Market Size, by Region, 2017-2025 ($Million)
Table 170 RoW: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 171 RoW: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 172 RoW: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 173 RoW: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 174 RoW: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 175 RoW: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 176 RoW: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 177 RoW: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 178 Latin America: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 179 Latin America: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 180 Latin America: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 181 Latin America: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 182 Latin America: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 183 Latin America: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 184 Latin America: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 185 Latin America: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 186 Cancer Incidence in Middle East and Africa, 2012-2030 (Number of New Cases)
Table 187 Interventional Oncology Conferences in Middle East & Africa
Table 188 Middle East & Africa: Interventional Oncology Market Size, by Procedure, 2017-2025 ($Million)
Table 189 Middle East & Africa: Tumor Embolization Market Size, by Procedure, 2017-2025 ($Million)
Table 190 Middle East & Africa: Tumor Ablation Market Size, by Procedure, 2017-2025 ($Million)
Table 191 Middle East & Africa: Thermal Ablation Procedure Market Size, by Type, 2017-2025 ($Million)
Table 192 Middle East & Africa: Tumor Embolization Market Size, by Product, 2017-2025 ($Million)
Table 193 Middle East & Africa: Tumor Ablation Market Size, by Product, 2017-2025 ($Million)
Table 194 Middle East & Africa: Interventional Oncology Market Size, by Application, 2017-2025 ($Million)
Table 195 Middle East & Africa: Interventional Oncology Market Size, by End User, 2017-2025 ($Million)
Table 196 Number of Developments by the Major Players During 2016-2019
Table 197 Interventional Oncology: Competitive Benchmarking

List of Figures

Figure 1 Research Process
Figure 2 Key Executives Interviewed
Figure 3 Primary Research Techniques
Figure 4 Market Size Estimation
Figure 5 Tumor Embolization Segment Dominates the Global Interventional Oncology Market
Figure 6 Global Interventional Oncology Market Size, by Application, 2019-2025 ($Million)
Figure 7 Global Interventional Oncology Market, by End User, 2019-2025 ($ Million)
Figure 8 Global Interventional Oncology Market Overview: 2019-2025
Figure 9 Number of Embolization Procedures Performed Globally for Treatment of Liver Cancer, 2016-2027 (In Thousands)
Figure 10 Number of Ablation Procedures Performed Globally, 2016-2027 (In Thousands)
Figure 11 Number of New Cancer Cases Across the Globe, 2012-2040 (In Million)
Figure 12 Cancer Related Deaths Globally, 2012-2040 (Cases in Millions)
Figure 13 Number of Private Hospitals in Australia: 2011-2012 and 2015-2016
Figure 14 Number of Doctors Per 1,000 Population, by Country, 2017
Figure 15 Proportion of Population Aged 60 Or Over in Asia, by Region, 2016-2050
Figure 16 Cancer Incidence in Asia: 2018-2040
Figure 17 Global Interventional Oncology Market Size, by Procedure, 2019-2025 ($Million)
Figure 18 Global Interventional Oncology Market Size, by Product, 2019-2025 ($Million)
Figure 19 Global Sir-Spheres Market Size, 2017-2025 ($Million)
Figure 20 Global TheraSphere Market Size, 2017-2025 ($Million)
Figure 21 Global QuiremSpheres Market Size, 2017-2025 ($Million)
Figure 22 Global Microspheres Market Size, 2017-2025 ($Million)
Figure 23 Global Embolization Particles Market Size, 2017-2025 ($Million)
Figure 24 Global Drug-Eluting Beads Market Size, 2017-2025 ($Million)
Figure 25 Global Interventional Oncology Market Size, by Application, 2019-2025 ($Million)
Figure 26 Number of New Liver Cancer Cases Worldwide (2012-2018)
Figure 27 Number of New Lung Cancer Cases in 2018, by Region (In Thousands)
Figure 28 Number of New Breast Cancer Cases Worldwide, (2012-2018)
Figure 29 Number of New Prostate Cancer Cases Globally, 2018-2030 (In Millions)
Figure 30 Global Incidence of Kidney Cancer, 2012-2018 (Number of Cancer Cases)
Figure 31 U.S: Number of New Stomach Cancer Cases and Related Deaths, 2012-2018
Figure 32 Global Interventional Oncology Market Size, by End User, 2019-2025 ($Million)
Figure 33 Number of Private Hospitals in China ,2013-2017
Figure 34 Number of Outpatient Care Centres in the U.S., 2010-2016
Figure 35 Number of Medicare-Certified Ambulatory Surgical Centres in U.S., 2009-2014
Figure 36 Global Burden of New Cancer Cases Across the World (In Millions)
Figure 37 Global Interventional Oncology Market Size, by Region, 2019-2025 ($Million)
Figure 38 North America: Interventional Oncology Market Size, by Country, 2019-2025 ($Million)
Figure 39 Number of New Cancer Cases in the U.S., 2012-2030 (Cases in Million)
Figure 40 Mortality from Cancer in the U.S., 2010-2040 (Number of Deaths Due to Cancer)
Figure 41 Total Cancer Expenditure in the U.S., 2010 & 2017 ($ Billion):
Figure 42 Number of Cancer Cases in Canada: 2017-2030
Figure 43 Total Health Expenditure of Canada, 2000-2017 ($ Billions)
Figure 44 Cancer Cases in Europe (In Millions): 2012-2040
Figure 45 Share of Breast Cancer Screening in Women Aged 50-69 in Europe, by Country, 2016 (%)
Figure 46 Europe: Interventional Oncology Market Size, by Country, 2019-2025 ($Million)
Figure 47 Share of Population Aged 65 and Above (As % of total Population), 2011-2018
Figure 48 Cancer Incidence and Mortality in Germany: 2018-2030 (Number of Cases)
Figure 49 Cancer Incidence and Mortality in France: 2018- 2040 (Number of Cases)
Figure 50 Healthcare Spending Per Capita in France, 2011-2017 ($)
Figure 51 Number of New Cancer Cases and Mortality in U.K.:2018-2040
Figure 52 Cost of Cancer Care in the U.K., 2011-2021 ($ Billion)
Figure 53 Cancer Incidence and Mortality in Italy,2018-2035 (Number of Cases)
Figure 54 Population Aged 65 Or Above in Spain (% of total Population
Figure 55 Cancer Incidence and Mortality in Spain, 2018-2040 (Number of Cases)
Figure 56 Cancer Incidence by Country: 2018-2040 (Number of Cases)
Figure 57 Per Capita Health Spending by Country, 2017 (In $PPP)
Figure 58 Asia Cancer Incidence by Region, 2012-2040 (Number of Estimated Cases)
Figure 59 Asia-Pacific: Interventional Oncology Market Size, by Country, 2019-2025 ($Million)
Figure 60 Share of Population Aged 65 and Over in Japan, 2000-2030 (% of total Population)
Figure 61 Cancer Incidence and Mortality in Japan, 2018-2040 (Number of Cases)
Figure 62 Number of New Cancer Cases and Related Mortality in China, 2018-2040 (Number of Cases)
Figure 63 Cancer Incidence and Mortality in India, 2018-2030-2040 (Number of Cases)
Figure 64 Proportion of Population Aged 60 Or Above in Asia, by Country, 2015-2030
Figure 65 Age Adjusted Rate of New Cancer Cases Per 100,000 Population, 2016
Figure 66 Cancer Incidence in RoW, by Country, 2018-2030 (Number of New Cases)
Figure 67 RoW: Interventional Oncology Market Size, by Region, 2019-2025 ($Million)
Figure 68 Cancer Incidence & Related Mortality in Latin America & Caribbean, 2018-2040 (Number of Cases)
Figure 69 Interventional Oncology Conferences in Latin America
Figure 70 Growth Strategies Adopted by Key Players (2016–2019)
Figure 71 Global Interventional Oncology Market Share, by Key Players, 2018 (%)
Figure 72 Boston Scientific Corporation: Financial Overview (2016-2018)
Figure 73 Merit Medical Systems, Inc.: Financial Overview (2016-2018)
Figure 74 Becton, Dickinson, and Company: Financial Overview (2016-2018)
Figure 75 Profound Medical Corp.: Financial Overview (2017-2018)
Figure 76 Angiodynamics, Inc.: Financial Overview (2016-2018)
Figure 77 BTG plc: Financial Overview (2016-2018)
Figure 78 Terumo Corporation: Financial Overview (2016-2018)
Figure 79 Medtronic plc: Financial Overview (2016-2018)
Figure 80 EDAP TMS S.A.: Financial Overview (2016-2018)
Figure 81 Johnson & Johnson: Financial Overview (2016-2018)
Figure 82 Sirtex Medical Limited: Financial Overview (2015-2017)
Figure 83 Teleflex Incorporated: Financial Overview: (2016-2018)

The global interventional oncology market is expected to grow at a CAGR of 7.7% from 2019 to reach $1,506.3 million by 2025. Interventional oncology is an emerging and rapidly growing offshoot of interventional radiology, which uses minimally invasive procedures for the diagnosis, treatment, and palliation of cancer patients. Growing preference for minimally invasive treatment procedures, increasing incidence of cancer, rising number of hospitals, and technological advancements in the field of radiology are the key factors driving the adoption of interventional oncology in many countries across the globe.

Increasing incidence of cancer is propelling the growth of interventional oncology market

Cancer is the second leading cause of death globally and was responsible for an estimated 9.6 million deaths in 2018. Approximately 70% of deaths from cancer occur in low- and middle-income countries. Late stage diagnosis and inaccessible treatment are the major factors responsible for rising mortality from cancer across the globe. According to the WHO, in 2017, only 26% of low-income countries reported having pathology services generally available in the public sector. More than 90% of high-income countries reported availability of treatment services. Similarly, according to GLOBOCAN, in 2012, about 14.1 million new cancer cases were diagnosed across the globe, which increased by ~28% to reach 18.1 million new cases in 2018. These numbers are further expected to rise to 29.5 million cases by 2040.

Moreover, the U.S. cancer care expenditure was $147.3 billion in 2017. In future, costs are likely to increase as the population ages and cancer incidence & prevalence increases. Therefore, factors such as increasing cancer incidence, rising cancer related healthcare expenditure, and demand for advanced cancer care options are driving the adoption of interventional oncology.

Significant opportunities from developing economies support the market growth

According to the Organization for Economic Co-operation and Development (OECD), health expenditure ($/capita) is consistently growing in developing regions. The growing health expenditure is a positive indicator for any medical device market including interventional oncology. Also, the growing health expenditure is an indicator of increasing patient access to the healthcare which ultimately leads to the development of improved medical facilities and associated treatment. According to the World Health Organization (WHO), in low- and middle-income countries, the health spending is growing on average 6% annually compared with 4% in high-income countries. Therefore, owing to aforementioned reasons, the adoption of advanced tools and equipment including interventional oncology procedures is increasing in the emerging countries across Asia and Latin American regions.

For In-Depth Detail Get Sample Copy:https://www.meticulousresearch.com/request-sample-report/cp_id=4951

Key Findings in the Global Interventional Oncology Market Study:

Tumor embolization procedures to witness the largest demand through 2025

Tumor embolization procedures commanded the largest share of the global interventional oncology market in 2018 mainly due to their wide usage with high sensitivity, specificity, and accuracy towards detection and characterization of tumors. In addition, the advancements in embolization procedures along with research programs for the improvement of yttrium 90 isotopes efficiency, has led to the increase in demand for embolization procedures worldwide.

Liver cancer to dominate the interventional oncology market by 2025

Liver cancer commanded the largest share of the global interventional oncology in 2018 primarily due to the availability of wide range of embolization and ablation products globally for liver cancer treatment and growing prevalence of the disease and related mortality. Furthermore, this segment is also estimated to grow at the highest CAGR of 8.0% during the forecast period with rising diagnosis and treatment rate of the disease with growing awareness about the fatality and benefits of early diagnosis and treatment across the globe, and growing access to innovative products and their increasing coverage for reimbursement.

Hospitals to dominate the global interventional oncology market

Hospitals commanded the largest share of the global interventional oncology market in 2018. Rising number of private hospitals in the emerging countries coupled with the large pool of cancer patient population visiting hospitals for diagnosis & treatment is driving the growth of this market. For instance, according to the Commonwealth Fund, the total number of hospitals in China has increased significantly over the last decade from roughly 18,700 in 2005 to ~27,600 hospitals in 2015 and ~31,056 in 2017. In addition to the above factors, rising reimbursement for interventional oncology procedures, improving healthcare infrastructure, and accessibility to hospitals globally are the key factors further supporting the growth of interventional oncology market in hospitals.

Asia-Pacific: The fastest growing regional market

North America commanded the largest share of the global interventional oncology market in 2018, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. However, Asia-Pacific will be the fastest growing regional market due to accelerated economic growth of many countries in this region and growing government focus on healthcare sector. In addition, government initiatives towards the development of healthcare facilities, rising incidence & prevalence of cancer; rising awareness towards overall health and treatment availability; growing number of middle class population and their level of disposable income; increasing health insurance penetration; and growing aging population in the region are the key factors propelling the growth of the Asia-Pacific interventional oncology market.

Key Players

The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 5 years (2016-2019). The key players profiled in the global interventional oncology market research report are Boston Scientific Corporation, C. R. Bard, Inc., Medtronic plc, Cook Medical LLC, Merit Medical Systems, Inc., Profound Medical Corp, AngioDynamics, Inc., BTG plc, Terumo Corporation, HealthTronics, Inc., EDAP TMS S.A., Neuwave Medical, Inc., Sirtex Medical Limited, Trod Medical, Teleflex Incorporated, Sanarus Technologies Inc., IMBiotechnologies Ltd., MedWaves, Inc., and IceCure Medical Ltd. 

Scope of the Report:

Market by Procedure

  • Tumor Embolization
    • Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy
    • Transcatheter Arterial Chemoembolization (TACE)
    • Transcatheter Arterial embolization/Bland Embolization
  • Tumor ablation
    • Thermal Ablation
      • Microwave Ablation
      • Radiofrequency Ablation
      • Cryoablation
      • Others (Laser and HIFU)
    • Non-thermal Ablation
      • Irreversible Electroporation

Market by Product

  • Tumor Embolization
    • Radioembolic agents
      • SIR-Spheres
      • TheraSphere
      • QuiremSpheres
    • Non-radioactive embolic agents
      • Microspheres
      • Drug-eluting beads
      • Particles
    • Tumor Ablation
      • Capital Ablation Devices/Generators
      • Consumables & Accessories

Market by Application

  • Liver Cancer
  • Lung Cancer
  • Breast Cancer
  • Prostate Cancer
  • Kidney Cancer
  • Bone Metastasis
  • Others

Market by End user

  • Hospital
  • Ambulatory Care Centers
  • Research & Academia

Market by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • India
    • Japan
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa.

Key questions answered in the report:

Growing penetration of interventional oncology procedures in developing countries will propel the overall interventional oncology market

  • How does the penetration of interventional oncology in developed regions differ from developing countries like India, and China?
  • How is the competition between the major global and prominent local players in this market?
  • Which are the high growth market segments in terms of procedure, product, end users, regions, and countries?

Hospitals accounted for the largest share of the interventional oncology market globally

  • What factors contribute to the frequent usage of overall interventional oncology products in hospitals?
  • Which geographic segment is expected to experience the fastest growth in the usage of interventional oncology products in hospitals, ambulatory care centres, and research & academia?
  • How does the penetration of interventional oncology in hospitals differ from other end users such as ambulatory care centres and research & academia?

Interventional oncology market favors both larger and local manufacturers that compete in multiple segments

  • What are the top competitors in this market and what strategies do they employ to gain shares?
  • What is driving growth and which market segments have the most potential for revenue expansion over the forecast period?
  • What strategies should new companies look to enter this market to compete effectively?
  • What are the major drivers, restraints, opportunities, and trends  in the interventional oncology market?
  • Who are the major players in various countries and what share of the market do they hold?
  • What are the geographical trends and high growth regions/ countries?

Recent partnerships, acquisitions, and expansions have taken place in the global interventional oncology market

  • What companies have recently merged/acquired and how will these unions affect the competitive landscape of the interventional oncology market?
  • What companies have created partnerships and how will these partnerships promote a competitive advantage?
  • Who are the major players in the global interventional oncology market and what share of the market do they hold?
  • What are the local emerging players in the global interventional oncology market and how do they compete with the global players?
This website is secure and we do not share your personal information with any third party. Privacy Policy
Tags: Healthcare Medical Technologies
Download Free Sample